Get all your news in one place.
100’s of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Health
Doug Bolton

Around half of Taiwan's population lack a gene required for metabolising alcohol

Glasses of beer at a restaurant promotion in Taipei, Taiwan (Getty)

Around half of the population of Taiwan lacks a gene that is required to properly metabolise alcohol, meaning many Taiwanese people can experience flushed faces, respiratory problems and even an increased risk of cancer when they drink.

As reported by the China Times, the percentage of people lacking the ALDH2 gene in Taiwan is higher than in any other nation, at 47 per cent.

The claims come from Che-Hong Chen, a senior research scientist at Stanford University's Mochly-Rosen Lab biological research institute.

Deficiency is common in east Asia, with 35 per cent lacking the gene in China, 30 per cent in Japan, and 20 per cent in South Korea.

While Europeans, most of whom carry the gene necessary to metabolise alcohol properly, are often told that small amounts of red wine can be beneficial to the cardiovascular system, this advice is not applicable to east Asians, according to the Stanford research.

Those lacking the gene can actually increase their risk of cancer, as the acetaldehyde in alcohol, which is usually easily metabolised those with the gene, builds up in the body.

Acetaldehyde is a probable carcinogen, meaning that ALDH2-deficient people can increase their risks of mouth, throat and esophagal cancers 50-fold through regular consumption of alcohol.

Read more:
Taiwan thriving in China's shadow
Kavalan whisky from Taiwan named best in the world
'Single fault' in one gene can lead to alcohol addiction in laboratory mice

Chen said that those curious to see if they have the gene or not can soak a plaster with an alcoholic drink and put it on their skin.

If the skin turns a reddish colour after 20 minutes, then it is likely that they lack the gene.

However, Taiwanese drinkers may soon have a solution - Chen said that a product that can 'activate' the deficient gene could be on the market within five to 10 years, meaning no more red faces during drinking sessions.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.